229 related articles for article (PubMed ID: 20404349)
1. Regulation of cyclin B2 expression and cell cycle G2/m transition by menin.
Wu T; Zhang X; Huang X; Yang Y; Hua X
J Biol Chem; 2010 Jun; 285(24):18291-300. PubMed ID: 20404349
[TBL] [Abstract][Full Text] [Related]
2. [The role and mechanism of high expression of cyclin B2 in MEN1 insulinoma].
Wu T; Huang XH
Sheng Li Xue Bao; 2011 Dec; 63(6):555-64. PubMed ID: 22193451
[TBL] [Abstract][Full Text] [Related]
3. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c.
Karnik SK; Hughes CM; Gu X; Rozenblatt-Rosen O; McLean GW; Xiong Y; Meyerson M; Kim SK
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14659-64. PubMed ID: 16195383
[TBL] [Abstract][Full Text] [Related]
4. Mutation of tumor suppressor gene Men1 acutely enhances proliferation of pancreatic islet cells.
Schnepp RW; Chen YX; Wang H; Cash T; Silva A; Diehl JA; Brown E; Hua X
Cancer Res; 2006 Jun; 66(11):5707-15. PubMed ID: 16740708
[TBL] [Abstract][Full Text] [Related]
5. Menin-mediated caspase 8 expression in suppressing multiple endocrine neoplasia type 1.
La P; Yang Y; Karnik SK; Silva AC; Schnepp RW; Kim SK; Hua X
J Biol Chem; 2007 Oct; 282(43):31332-40. PubMed ID: 17766243
[TBL] [Abstract][Full Text] [Related]
6. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome.
Gurung B; Feng Z; Iwamoto DV; Thiel A; Jin G; Fan CM; Ng JM; Curran T; Hua X
Cancer Res; 2013 Apr; 73(8):2650-8. PubMed ID: 23580576
[TBL] [Abstract][Full Text] [Related]
7. Menin mediates epigenetic regulation via histone H3 lysine 9 methylation.
Yang YJ; Song TY; Park J; Lee J; Lim J; Jang H; Kim YN; Yang JH; Song Y; Choi A; Lee HY; Jo CH; Han JW; Kim ST; Youn HD; Cho EJ
Cell Death Dis; 2013 Apr; 4(4):e583. PubMed ID: 23579270
[TBL] [Abstract][Full Text] [Related]
8. Direct binding of DNA by tumor suppressor menin.
La P; Silva AC; Hou Z; Wang H; Schnepp RW; Yan N; Shi Y; Hua X
J Biol Chem; 2004 Nov; 279(47):49045-54. PubMed ID: 15331604
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.
Dreijerink KM; Höppener JW; Timmers HM; Lips CJ
Nat Clin Pract Endocrinol Metab; 2006 Oct; 2(10):562-70. PubMed ID: 17024155
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide characterization of menin-dependent H3K4me3 reveals a specific role for menin in the regulation of genes implicated in MEN1-like tumors.
Agarwal SK; Jothi R
PLoS One; 2012; 7(5):e37952. PubMed ID: 22666422
[TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression.
Chen YX; Yan J; Keeshan K; Tubbs AT; Wang H; Silva A; Brown EJ; Hess JL; Pear WS; Hua X
Proc Natl Acad Sci U S A; 2006 Jan; 103(4):1018-23. PubMed ID: 16415155
[TBL] [Abstract][Full Text] [Related]
12. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
[TBL] [Abstract][Full Text] [Related]
13. Multiple endocrine neoplasia type 1: a chromatin writer's block.
Dreijerink KM; Lips CJ; Timmers HT
J Intern Med; 2009 Jul; 266(1):53-9. PubMed ID: 19522825
[TBL] [Abstract][Full Text] [Related]
14. Menin links estrogen receptor activation to histone H3K4 trimethylation.
Dreijerink KM; Mulder KW; Winkler GS; Höppener JW; Lips CJ; Timmers HT
Cancer Res; 2006 May; 66(9):4929-35. PubMed ID: 16651450
[TBL] [Abstract][Full Text] [Related]
15. Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer.
Dreijerink KMA; Groner AC; Vos ESM; Font-Tello A; Gu L; Chi D; Reyes J; Cook J; Lim E; Lin CY; de Laat W; Rao PK; Long HW; Brown M
Cell Rep; 2017 Mar; 18(10):2359-2372. PubMed ID: 28273452
[TBL] [Abstract][Full Text] [Related]
16. Menin directly represses Gli1 expression independent of canonical Hedgehog signaling.
Gurung B; Feng Z; Hua X
Mol Cancer Res; 2013 Oct; 11(10):1215-22. PubMed ID: 23928057
[TBL] [Abstract][Full Text] [Related]
17. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
Milne TA; Hughes CM; Lloyd R; Yang Z; Rozenblatt-Rosen O; Dou Y; Schnepp RW; Krankel C; Livolsi VA; Gibbs D; Hua X; Roeder RG; Meyerson M; Hess JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):749-54. PubMed ID: 15640349
[TBL] [Abstract][Full Text] [Related]
18. The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation.
Dreijerink KM; Varier RA; van Beekum O; Jeninga EH; Höppener JW; Lips CJ; Kummer JA; Kalkhoven E; Timmers HT
Mol Cell Biol; 2009 Sep; 29(18):5060-9. PubMed ID: 19596783
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressor menin regulates expression of insulin-like growth factor binding protein 2.
La P; Schnepp RW; D Petersen C; C Silva A; Hua X
Endocrinology; 2004 Jul; 145(7):3443-50. PubMed ID: 15044367
[TBL] [Abstract][Full Text] [Related]
20. Multi-omics analyses of MEN1 missense mutations identify disruption of menin-MLL and menin-JunD interactions as critical requirements for molecular pathogenicity.
Dreijerink KMA; Ozyerli-Goknar E; Koidl S; van der Lelij EJ; van den Heuvel P; Kooijman JJ; Biniossek ML; Rodenburg KW; Nizamuddin S; Timmers HTM
Epigenetics Chromatin; 2022 Aug; 15(1):29. PubMed ID: 35941657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
